[1]
|
D. F. Scott, “The History of Epileptic Therapy: An Account of How Medication was Developed,” Taylor & Francis, London, 1993.
|
[2]
|
N. F. Moran, K. Poole, G. Bell, J. Solomon, S. Kendall, J. Solomon, S. Kendall, M. McCarthy, D. McCormick, L. Nashef, J. Sander and S. D. Shorvon, “Epilepsy in the United Kingdom: Seizure Frequency and Severity, Anti- Epileptic Drug Utilization and Impact on Life in 1652 People with Epilepsy,” Seizure, Vol. 13, No. 6, 2004, pp. 425-433. doi:10.1016/j.seizure.2003.10.002
|
[3]
|
R. Sridharan, “Epidemiology of Epilepsy,” Current Science (India), Vol. 82, No. 6, 2002, pp. 664-670.
|
[4]
|
N. Senanayake and G. C. Roman, “Epidemiology of Epilepsy in Developing Countries,” Bulletin of the World Health Organization, Vol. 71, No. 2, 1993, pp. 247-258.
|
[5]
|
www.fda.gov
|
[6]
|
P. Kwan and M. J. Brodie, “Early Identification of Re- fractory Epilepsy,” New England Journal of Medicine, Vol. 342, No. 5, 2000, pp. 314-319.
|
[7]
|
W. L?scher and D. Schmidt, “Modern Antiepileptic Drug Development Has Failed to Deliver: Ways Out of the Current Dilemma,” Epilepsia, Vol. 52, No. 4, 2011, pp. 657-678. doi:10.1111/j.1528-1167.2011.03024.x
|
[8]
|
C. J. Landmark, “Antiepileptic Drugs in Non-Epilepsy Disorders: Relations between Mechanisms of Action and Clinical Efficacy,” CNS Drugs, Vol. 22, No. 1, 2008, pp. 27-47.
|
[9]
|
W. Raasch, “Antiepileptic Drug Market,” 2011.
http://www.wikinvest.com/wiki/Antiepileptic_Drug_Market
|
[10]
|
http://www.drugbank.ca
|
[11]
|
U. Calis, S. Dalkara and M. Ertan, “Synthesis and Anticonvulsant Activity of Some New 4-Aryl-1,3-Dihydro- 2H-Imidazol-2-One Derivatives,” Arzneimittel Forschung, Vol. 42, No. 5, 1992, pp. 592-594.
|
[12]
|
M. Amir and E. Singh, “1-p-(2-Arylimino-thiazolidon-3- yl)phenyl-2-methyl-4-arylidene-5-imidazolones as anticon- vulsants,” Acta Pharmaceutica, Vol. 42, No. 5, pp. 133- 137.
|
[13]
|
H. Joshi, P. Upadhyay, D. Karia and A. J. Baxi, “Synthesis of Some Novel Imidazolinones as Potent Anticonvulsant Agents,” European Journal of Medicinal Chemistry, Vol. 38, No. 9, 2003, pp. 837-840.
doi:10.1016/S0223-5234(03)00117-X
|
[14]
|
H. S. White, J. H. Woodhead, M. R. Franklin, E. A. Swinyard and H. H. Wolf, “General Principles: Experimental Selection, Quantification, and Evaluation of Antiepileptic Drugs,” In: R. H. Levy, R. H. Mattson and B. S. Meldrum, Eds., Antiepileptic Drugs, 4th Edition, Raven Inc., New York, 1995, pp. 99-121.
|
[15]
|
J. R. Boissier, J. Tardy and J. C. Diverres, “Une Nouvelle Methode Simple Pour Explorer l’Action Tranquilisante: Le Test de la Cheminee,” The Journal of Experimental Medicine, Vol. 3, 1960, pp. 81-84.
|
[16]
|
Molinispiration Cheminformatics, “Calculation of Mole- cular Properties and Bioactivity Score,” 2011.
http://www.molinspiration.com/cgi-bin/properties
|
[17]
|
P. Ertl, B. Rohde and P. Selzer, “Fast Calculation of Molecular Polar Surface Area as a Sum of Fragment Based Contributions and Its Application to the Prediction of Drug Transport Properties,” Journal of Medicinal Che- mistry, Vol. 43, No. 20, 2000, pp. 3714-3717.
doi:10.1021/jm000942e
|
[18]
|
P. Raghavendra, G. Veena, G. A. Kumar, E. R. Kumar, N. Sangeetha, B. Sirivennela, S. Smarani, H. Kumar, S. Praneeth and R. Suthakaran, “Microwave Synthesis and Anti-Inflammatory Evaluation of Some New Imidazolo Quinoline Analogs,” RASAYAN Journal of Chemistry, Vol. 4, No. 1, 2011, pp. 91-102.
|
[19]
|
B. M. Trost and P. J. Morris, “Palladium-Catalyzed Dia- stereo- and Enantioselective Synthesis of Substituted Cyclo- pentanes through a Dynamic Kinetic Asymmetric Formal [3 + 2]-Cycloaddition of Vinyl Cyclopropanes and Alky- lidene Azlactones,” Angewandte Chemie International Edi- tion, Vol. 50, No. 27, pp. 6167-6170.
doi:10.1002/anie.201101684
|
[20]
|
M. Kidwai and R. Mohan, “Solid Supported Reaction of Substituted 2-Oxazoline with Amines under Microwave Irradiation,” Journal of the Chinese Chemical Society, Vol. 50, No. 5, 2003, pp. 1075-1078.
|
[21]
|
C. W. Bird and J. D. Twibell, “Rearrangement of 3-(Acy- lamino)Azetidinones,” Journal of the Chinese Chemical Society, Vol. 19, 1971, pp. 3155-3158.
|
[22]
|
P. Kumar and K. A. Mukerjee, “Synthesis of 4-Arylidene- 1,2-Disubstituted-Δ2-Imidazolin-5-Ones,” Indian Journal of Chemistry—Section B: Organic and Medicinal Che- mistry Indian, Vol. 20B, No. 5, 1981, pp. 416-418.
|
[23]
|
M. Z. A. Badr, H. A. H. El-Sherief and M. E. Tadros, “Synthesis of 1,2-Disubstituted-4-Benzylidene-2-Imida- zolin-5-Ones and Their Thione Derivatives,” Indian Jour- nal of Chemistry—Section B: Organic and Medicinal Che- mistry Indian, Vol. 18, No. 3, pp. 240-242.
|
[24]
|
A. S. Girgis, “Facile Regioselective Synthesis of 1,2,6,8- Tetraazaspiro[4.4]Nona-2,6-Dien-9-Ones,” Zeitschrift für Naturforschung B (Chemical Sciences), Vol. 31, No. 24, 2010, pp. 222-226.
|
[25]
|
O. A. Miqdad, N. M. Abunada and H. M. Hassaneen, “Regioselectivity of Nitrilimines 1,3-Dipolar Cycloaddi- tion: Novel Synthesis of Spiro[4,4] Nona-2,8-Dien-6-One Derivatives,” Heteroatom Chemistry, Vol. 22, No. 2, 2011, pp. 131-136. doi:10.1002/hc.20666
|
[26]
|
M. A. Abdallah, M. E. Zayed and A. S. Shawali, “Reaction of Benzonitrilium N-Phenylimide with (Z)-4-Ary- lmethyleneimidazol-5(4H)-Ones,” Indian Journal of Che- mistry—Section B: Organic and Medicinal Chemistry Indian, Vol. 40, No. 3, pp. 187-190.
|
[27]
|
F. M. Ismail and N. G. Kandile, “Reaction of 4-(Ary- lmethylene)-2-Phenyl-2-Oxazolin-5-Ones with Schiff Bases and Benzalazine,” Asian Journal of Chemistry, Vol. 1, No. 3, 1989, pp. 254-260.
|
[28]
|
G. V. S. R. Sarma and V. M. Reddy, “1,2-Disubstituted -4-[(Furan-2-yl)Methylene]Imidazolin-5(4H)-Ones,” Jour- nal of the Institution of Chemists (India), Vol. 72, No. 3, 2000, pp. 106-110.
|